Catalio Capital Management, LP Sensei Biotherapeutics, Inc. Transaction History
Catalio Capital Management, LP
- $457 Billion
- Q4 2024
A detailed history of Catalio Capital Management, LP transactions in Sensei Biotherapeutics, Inc. stock. As of the latest transaction made, Catalio Capital Management, LP holds 294,374 shares of SNSE stock, worth $141,299. This represents 0.03% of its overall portfolio holdings.
Number of Shares
294,374Holding current value
$141,299% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding SNSE
# of Institutions
26Shares Held
2.4MCall Options Held
0Put Options Held
0-
Ikarian Capital, LLC Dallas, TX650KShares$311,9820.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA594KShares$285,3370.0% of portfolio
-
Boothbay Fund Management, LLC New York, NY173KShares$82,9430.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny157KShares$75,2640.0% of portfolio
-
Geode Capital Management, LLC Boston, MA149KShares$71,4650.0% of portfolio
About Sensei Biotherapeutics, Inc.
- Ticker SNSE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,720,300
- Market Cap $14.7M
- Description
- Sensei Biotherapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of immunotherapies with an initial focus on treatments for cancer. It develops proprietary ImmunoPhage platform, an immunotherapy approach that is designed to utilize bacteriophage to induce a focused and coordinated innate and adaptive immune res...